HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Dihydroergocristine Mesylate

HCID 444034
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
24730-10-7
Standard SMILES
CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O
InChIKey
SPXACGZWWVIDGR-SPZWACKZSA-N
Molecular formula
C36H45N5O8S
Average molar mass
707.8 g/mol
Monoisotopic mass
707.29888458

Overview

Dihydroergocristine mesylate is the methanesulfonic acid salt of dihydroergocristine. It has been used as the for the symptomatic treatment of mental deterioration associated with cerebrovascular insufficiency and in peripheral vascular disease. It is also a component of ergoloid mesylate (codergocrine mesilate), a mixture of ergot alkaloid derivatives that is used as a vasodilator and has shown mild benefits in the treatment of vascular dementia. It has a role as a geroprotector, a vasodilator agent and an alpha-adrenergic antagonist. It contains a dihydroergocristine.

Names & identifiers

Preferred name
Dihydroergocristine Mesylate
IUPAC
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
English name
Dihydroergocristine mesylate
Molecular formula
C35H41N5O5.CH4O3S
Molecular weight
707.84

Names & synonyms

DIHYDROERGOCRISTINE MESYLATE24730-10-7Dihydroergocristine mesilate9,10-Dihydroergocristine methanesulfonateDihydroergocristinmesilatDS7CL18UAMDihydroergocristine methanesulfonateDihydroergocristine MonomesylateCHEBI:31490DTXSID208723225'alpha-Benzyl-9,10alpha-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione monomethanesulphonateErgotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'alpha,10alpha)-, monomethanesulfonate (salt)
Show more names
C13168DHEC (mesylate)Dihydroergocristine mesilate CRSDihydroergocristine mesilate (D1945000)dihydroergocristine methanesulfonate saltDIHYDROERGOCRYSTINE METHANESULFONATE SALTDihydroergocristine Mesilate For Assay CRS
RefChem:60099Mesylate, DihydroergocristineMonomesylate, DihydroergocristineDTXCID50819962246-434-6Dihydroergocristine (mesylate)oxamide methanesulfonateMLS000069354

Properties

Computed structural properties

Topological polar surface area
181 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
9
Rotatable bonds
5
Heavy atoms
50
Formal charge
0
Complexity
1,300

Physicochemical properties

Melting point
210 °C · 210 °C
storage temp.
Store at RT
solubility
2 O: · H2O: 10 mg/mL
form
Solid
color
White to off-white
InChIKey
SPXACGZWWVIDGR-NKQTVNRENA-N
FDA UNII
7 CL18UAM · DS7CL18UAM
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
303 · H303
Precautionary statements
270 · P270-P301+P312-P403-P501c
RIDADR
1544 · UN 1544 6.1/PG 2
WGK Germany
2 · 2
RTECS
7600000 · KE7600000
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
29396900 · 29396900

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P301+P317, P304+P340, P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

wgk
2
rtecs
KE7600000
ridadr
UN 1544 6.1/PG 2
hs_code
29396900
Signal word
Warning
Symbol(GHS)
GHS07
hazard_class
6.1(b)
packing_group
III
Hazard statements
H303
Precautionary statements
P270-P301+P312-P403-P501c

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Drugs used to cause dilation of the blood vessels.

Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.

Applications · 3 items

Uses5-HT receptor antagonist; partial agonist at adrenergic and dopaminergic receptors

UsesAlpha receptor blocking

Uses4,10-Dihydroergocristine Methanesulfonate is an nontoxic and well tolerated drug that exerts agonistic and antagonistic activity on dopaminergic and adrenergic receptors. 4,10-Dihydroergocristine Meth anesulfonate is known to exhibit protective properties to the brain against metabolic effects of ischemia by acting at a cellular level.

Additional notes · 1 item

DefinitionChEBI: The methanesulfonic acid salt of dihydroergocristine. It has been used as the for the symptomatic treatment of mental deterioration associated with cerebrovascular insufficiency and in peripheral vascular disease. It is also a component of ergoloid mesylat (codergocrine mesilate), a mixture of ergot alkaloid derivatives that is used as a vasodilator and has shown mild benefits in the treatment of vascular dementia.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes

Database identifiers

CAS
24730-10-7
PubChem CID
444034
DTXSID
DTXSID20872322
ChEMBL
CHEMBL1255837
ChEBI
CHEBI:31490
UNII
DS7CL18UAM
EC Number
246-434-6